The Court of Justice of the European Union today ruled that “the holder of a patent and a supplementary protection certificate for a medicinal product may not enjoy more than 15 years of exclusivity from the first marketing authorization issued in any Member State.”

The EU has created the supplementary protection certificate in order to regulate patent application for medicinal products. The certificate can be granted for a maximum duration of five years, however, the total duration may not e...


This story is part of New Europe's Premium content.

To Read the Full Story, Subscribe or Sign In from the ↑ Top of the Page ↑
new europe join now